Page last updated: 2024-10-30

meclofenamic acid and Leukemia, Pre-B-Cell

meclofenamic acid has been researched along with Leukemia, Pre-B-Cell in 1 studies

Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Giordano, L1
Moldwin, RL1
Downie, PA1
Goldberg, A1
Gupta, R1
Allen, R1
Aithal, NH1
Kim, DH1
Le Moine, PJ1
Smith, SD1

Other Studies

1 other study available for meclofenamic acid and Leukemia, Pre-B-Cell

ArticleYear
Growth inhibition of B-cell precursor acute lymphoblastic leukemia cell lines by monocytes: a role for prostaglandin E2.
    Leukemia research, 1997, Volume: 21, Issue:10

    Topics: Adult; Cell Count; Cell Division; Child; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Indomethac

1997